RP-1828 IMMUcan clinical trials

SPECTA: Screening Cancer Patients for Efficient Clinical Trial Access

This study, called SPECTA, collects information and samples from cancer patients to help scientists better understand cancer. It aims to improve how we diagnose and treat different types of cancer in the future by looking at many different aspects of the disease.